Qidu pharmaceutical's high-speed glass bottle infu

  • Detail

Qidu pharmaceutical's high-speed glass bottle infusion production line was completed and put into operation

interview with Shandong Qidu Pharmaceutical Co., Ltd. on August 16, what impressed me most was the enterprise's never-ending pace of innovation. Zhang Zhaoli, deputy secretary of the Party committee of Qidu Pharmaceutical Co., Ltd., who accompanied the interview, led the audience to watch the "Qidu pharmaceutical science and Technology Park" newly built by the enterprise, which covers an area of 476 mu, showing the strong development trend and the spirit of continuous innovation of the enterprise

according to Zhang Zhaoli, "Qidu pharmaceutical science and Technology Park" is a key project approved by the provincial government. It is one of the "three o projects" in Zibo, with a total investment of 550million yuan. After all the projects are put into operation, the industrial output value can be increased by 1billion yuan, and the profit and tax can be increased by 150million yuan

at present, the high-speed glass bottle infusion production line of the first phase of the project has been completed and put into operation. The other two production lines have also been built and are expected to occupy the largest market share. They have passed the national GMP certification and will be officially put into operation in September. By the end of the year, the new output value will be 60million yuan, and the new profit and tax will be more than 10million yuan. The project has become the largest economic growth point of Qidu Pharmaceutical Co., Ltd. In recent years, Qidu Pharmaceutical Co., Ltd. has adhered to the premise of quality-oriented, adhered to scientific and technological innovation, and continuously strengthened the independent innovation ability of the enterprise. It has successively worked closely with Shandong University, Shandong University of traditional Chinese medicine, Shenyang Pharmaceutical University and other colleges and universities and scientific research institutions to jointly develop new products

at the same time, it pays attention to the road of independent innovation, establishes the company's scientific research and development center, and gradually develops into a provincial enterprise science and technology center, laying a solid foundation for enterprises to independently develop new products. The company is willing to invest in product innovation. In recent years, it has successively invested 20million yuan in new drug research and development, with a total of more than 100 new products developed and more than 20 new drug certificates obtained, which not only ensures the continuous introduction of new drugs to the market, but also establishes product advantages for the rapid development of the enterprise in the future. According to statistics, the sales revenue and profits and taxes generated by the use of parameter products in the new Jinan assaying safety belt impact testing machine produced by Qidu Pharmaceutical Co., Ltd. have accounted for more than 80% of the total sales revenue and profits and taxes of the enterprise. Product innovation has become the wings of Qidu Pharmaceutical Co., Ltd. It is the continuous innovation of technology, process and products that makes the enterprise develop into a pivotal backbone enterprise in the same industry in the country. At present, the company produces seven series of pharmaceutical products with more than 100 specifications, including high-capacity injections, tablets, capsules, granules, syrups, raw materials, etc. the annual production capacity of the leading product high-capacity injections is 500 million bottles (bags), ranking first in Shandong Province and the top five in the country. The company has become one of the first batch of GMP comprehensive certification enterprises in the country, and the national torch plan. According to the data provided by the announcement, it plans to be a key high-tech enterprise, a backbone enterprise in the national biomedical industry, a major infusion production base in the country, and the top 500 largest pharmaceutical enterprises in the country. It is the pressing plate industry used by high-tech enterprises in Shandong Province for tightening experiments and compacting tablets. In 2006, the industrial output value of the enterprise will reach 400million yuan, the sales revenue will reach 350million yuan, and the profit and tax will reach 40million yuan

source: Zibo

Copyright © 2011 JIN SHI